Reducing mortality from childhood pneumonia and diarrhoea:The leading priority is also the greatest opportunity by Rudan, Igor et al.
  
 
 
 
Edinburgh Research Explorer 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Reducing mortality from childhood pneumonia and diarrhoea
Citation for published version:
Rudan, I, Nair, H, Maruši, A & Campbell, H 2013, 'Reducing mortality from childhood pneumonia and
diarrhoea: The leading priority is also the greatest opportunity' Journal of Global Health, vol 3, no. 1, pp.
10101. DOI: 10.7189/jogh.03.010101
Digital Object Identifier (DOI):
10.7189/jogh.03.010101
Link:
Link to publication record in Edinburgh Research Explorer
Document Version:
Publisher's PDF, also known as Version of record
Published In:
Journal of Global Health
Publisher Rights Statement:
Copyright © 2013 by the Journal of Global Health. All rights reserved.
This is an open access article distributed under the Creative Commons Attribution License, which permits
unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is
properly cited.
General rights
Copyright for the publications made accessible via the Edinburgh Research Explorer is retained by the author(s)
and / or other copyright owners and it is a condition of accessing these publications that users recognise and
abide by the legal requirements associated with these rights.
Take down policy
The University of Edinburgh has made every reasonable effort to ensure that Edinburgh Research Explorer
content complies with UK legislation. If you believe that the public display of this file breaches copyright please
contact openaccess@ed.ac.uk providing details, and we will remove access to the work immediately and
investigate your claim.
Download date: 28. Apr. 2017
ED
IT
O
RI
A
L
P
neumonia and diarrhoea have been the leading 
causes of global child mortality for many decades [1]. 
Their relative importance in comparison to other 
causes of child deaths, such as malaria, preterm birth, birth 
asphyxia, accidents, neonatal infections and cancer, has be-
come fully appreciated in 2003 through the work of the 
World Health Organization's and UNICEF's Child Health 
Epidemiology Reference Group (CHERG) [2]. The “Child 
Survival” series, published by The Lancet, has been pivotal 
in raising awareness that the UN’s Millennium Development 
Goal 4 cannot be achieved without increased focus on pre-
venting and treating childhood infections – particularly 
pneumonia and diarrhoea – in low– and middle–income 
countries [3]. The next big step involved the “Global Action 
Plan for Pneumonia” (GAPP), which summarized the evi-
dence on the epidemiology of acute lower respiratory infec-
tions in children, the key etiological agents, the main deter-
minants of the disease, the available and emerging solutions 
and the main obstacles to their implementation [4]. GAPP’s 
landmark publication in 2008 showed that there are about 
156 million new cases of pneumonia each year, and that 
about one in ten results in a severe episode that requires 
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hospitalization, and a further 10% of severe episodes lead 
to deaths of affected children [5]. The paper also proposed 
that Streptococcus pneumoniae (SP), Haemophilus influenzae 
type B (Hib), respiratory syncytial virus (RSV) and influen-
za virus are the pathogens whose interplay is the most like-
ly cause of the large majority of pneumonia deaths in chil-
dren under five years of age [5]. This led to increased 
attention to pneumonia prevention through available vac-
cines against PC, Hib and influenza virus, to complement 
existing (antibiotic) case management strategies, including 
those delivered by community health workers. The under-
developed and weak health systems in low–resource set-
tings, where most deaths occur, cannot easily scale up anti-
biotic coverage to children who need them most, because 
of relatively low rates of access to health care [6]. Another 
obstacle to progress is infrequent care–seeking among par-
ents who did not receive adequate education on this impor-
tant health issue [6].
Four papers that followed the GAPP initiative, all of them 
published by The Lancet, have estimated the global and 
regional burden of SP [7], Hib [8], RSV [9] and influenza 
[10]. In parallel to understanding the burden of specific 
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pathogens, new financial mechanisms have been developed 
– such as the Advance Market Commitment (AMC) – to 
reduce the prices of available vaccines and deliver them in 
low– and middle–income countries, where they would oth-
erwise remain unaffordable to local governments [11]. The 
Global Alliance for Vaccines and Immunization (now called 
the GAVI Alliance) has been set up to raise funding to pur-
chase these vaccines, with major contributions from the Bill 
and Melinda Gates Foundation who stood firmly behind 
the initiative to vaccinate children and prevent respiratory 
infections [12]. Those efforts ensured that most children in 
low–resource settings have received Hib vaccination by 
2010, and pneumococcal vaccination coverage is also now 
being scaled up globally [13].
The similar effort for diarrhoea has been lagging behind 
until recently, when an international collaboration of re-
searchers launched a “Diarrhoea Global Action Plan” 
(DGAP) [14]. Under the co–ordination of UNICEF, the 
World Health Organization, and USAID, the initiative has 
been merged with GAPP into “GAPPD” – “Global Action 
Plan for Pneumonia and Diarrhoea” [15]. This was a wel-
come move, because many risk factors are shared between 
the two diseases, and many approaches to control them 
could be delivered in parallel through an Integrated Man-
agement of Childhood Illness (IMCI) approach. Commu-
nities of researchers and policy–makers who are focused 
on diarrhoea control have also recently acquired the first 
vaccine effective in preventing an appreciable portion of 
the burden – rotavirus vaccine [16]. This vaccine will be 
added to GAVI portfolio to supplement PC and Hib vac-
cines for pneumonia [17].
The GAPPD group has recently been invited by The Lancet 
to write a series of papers that jointly address the epidemi-
ology of childhood diarrhoea and pneumonia, the available 
cost–effective interventions, country–specific challenges 
and bottlenecks, and suggest policies that could accelerate 
progress in reduction of global mortality from the two dis-
eases [15,18,19]. The series proposed that scaling up of 
existing highly cost–effective interventions could prevent 
95% of diarrhoea deaths and 67% of pneumonia deaths in 
children younger than 5 years by the year 2025, if deliv-
ered at scale. The cost of this effort was estimated at about 
US$ 6.7 billion [15,18,19]. These activities, along with in-
creased political stability in many low– and middle–income 
countries, their economic development, improved sanita-
tion and access to care, progress in empowering and edu-
cating women in the society and strengthening health sys-
tems, could all contribute to very substantial reduction of 
the global burden of child mortality attributable to pneu-
monia and diarrhoea [18,20,21]. We should, therefore, 
conclude that addressing childhood pneumonia and diar-
rhoea is not only the leading priority, but also possibly the 
greatest opportunity in global health today.
There is a growing consensus that an improved under-
standing of the size of the burden, the leading risk factors 
and the relative contribution of the leading etiological 
causes; the available vaccines and other cost–effective in-
terventions, such as community case management with 
antibiotics, oral rehydration sachets and zinc supplemen-
tation; and the momentum that many low– and middle–
income countries have gathered in improving their eco-
nomic outlook, have all provided the international health 
community with an unprecedented opportunity to sub-
stantially reduce the mortality from childhood pneumonia 
globally over the period of the next decade [15].
To support those ongoing initiatives, several leading medi-
cal journals published special issues, or series of articles, 
focused on childhood diarrhoea and pneumonia (and child 
survival in general) in the first half of 2013. As noted above, 
The Lancet will publish a four–paper series on childhood 
diarrhoea and pneumonia in April 2013, which is likely to 
have very large impact on the field [15,18,19]. PLoS Medi-
cine published a PloS Medicine Collection on improving in-
tervention delivery progress tracking and information sys-
tems in low–resource settings that could guide policy deci-
sions. BMC Public Health is expected to publish a series of 
reviews that will present results of meta–analyses of the ef-
fectiveness of several key child health interventions, such as 
breastfeeding and vaccination, which should further 
strengthen the evidence base for the Lives Saved Tool (LiST) 
[22]. In this issue, Journal of Global Health joins this coordi-
nated international effort launched by the CHERG group. 
We are bringing together several articles that should fill the 
remaining gaps in understanding acute respiratory infec-
tions and diarrhoeal disease in children. Rudan et al. revise 
national–level estimates of the morbidity, severe morbidity, 
mortality, etiology and risk factors for acute lower respira-
tory infections for 2010 [23]. Fischer–Walker et al. provide 
an assessment of co–morbidity between childhood pneu-
monia and diarrhoea [24]. Zwisler et al. use surveys to study 
the perception and use of oral rehydration sachets, antibi-
otics, and other therapies for diarrhoea in India and Kenya 
[25]; Wilson et al. analyse scaling up access to oral rehydra-
tion solution for diarrhea, learning from historical experi-
ence in low– and high–performing countries [26]; Simpson 
et al. add to this work by surveying caregivers in Kenya to 
assess perceptions of zinc as a treatment for diarrhea [27]. 
Finally, Zipursky et al. report on the global action plan for 
childhood diarrhea and show how research priorities were 
developed within this effort [14].
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The authors informed the publisher that the term Democratic Republic of Con-
go (capital: Kinshasa) was used instead of the correct name of the country – Re-
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the online version of the article.
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